Tarsus Pharmaceuticals, Inc. Schedules Conference Call and Webcast to Announce Saturn-1 Phase 2b/3 Pivotal Trial Results for TP-03 for the Treatment of Demodex Blepharitis
IRVINE, Calif., June 18, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late…
Wintermar Offshore (WINS:JK) Reports 9M2025 Results
Star Plus Legend (6683.HK) Becomes a Strategic Shareholder of Galaxy
Geekvape SOUL II Wins 2025 MUSE Gold Award – A Testament to Strength and Innovation
AI Pets Platform FurGPT Prepares to List FGPT Token on Binance Exchange and Aster DEX
Beyond Music, Beyond Worlds – X:THELABEL Rewrites the Rules of Virtual K-Pop